C-24WPGameto
cell engineering, iPSC-derived technology, ovarian support cells
replacementreplacingcell therapy
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-24WP
C-24WPC-24WPcell engineering, iPSC-derived technology, ovarian support cells
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Gameto cell engineering, iPSC-derived technology, ovarian support cells
Gameto is a biotechnology company focused on unmet needs in women's reproductive health from egg freezing and IVF through ovarian disease and menopause. Its cell engineering platform is used in Fertilo, a lead program designed to mature eggs outside the body with engineered ovarian cells. The site also describes Deovo for ovarian disease drug testing and Ameno for menopause-related cell therapy.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Gameto — Early mechanism · Bottom quartile. Derived deterministically from 5 extracted project(s). Most-advanced status: preclinical. Band: early_mechanism. Aging-relevance not LLM-reviewed in this pass.
Source: Deterministic